Assessing the impact of the COVID-19 pandemic on uptake and experiences of gestational diabetes mellitus screening in Ontario: A parallel convergent mixed-methods study
Despite health system challenges experienced in Ontario during the COVID-19 pandemic, GDM screening rates increased in the study population, demonstrating the success of adapted GDM screening guidelines. Decisions about screening modalities were driven by clinician expertise, and interview participants were satisfied to provide informed consent to these recommendations.
Authors
- Michelle Howard (ORCID: https://orcid.org/0000-0001-8127-5492)
- Dima Hadid (ORCID: https://orcid.org/0000-0001-7610-2984)
- Andrea Carruthers
- Meredith Vanstone (ORCID: https://orcid.org/0000-0002-7347-6259)
- Aaron Jones
- Rebecca H. Correia (ORCID: https://orcid.org/0000-0003-2949-2400)
- Sarah D. McDonald (ORCID: https://orcid.org/0000-0002-4461-2178)
- Devon Greyson (ORCID: https://orcid.org/0000-0003-4860-384X)
- Cassandra Kuyvenhoven (ORCID: https://orcid.org/0000-0003-4238-7728)
- David H. Kirkwood (ORCID: https://orcid.org/0000-0002-5147-8210)
- Sujane Kandasamy (ORCID: https://orcid.org/0000-0003-4326-2783)
- Elizabeth K. Darling
Institutions
- University of British Columbia (CA)
- Brock University (CA)
- Impact (CA)
- McMaster University (CA)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1371/journal.pone.0315983
- Primary Topic
- Gestational Diabetes Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Public Health Agency of Canada
- Michael Smith Health Research BC
- Canada Research Chairs
- Canadian Institutes of Health Research